What is KeyCorp’s Estimate for Albemarle Q1 Earnings?

Albemarle Co. (NYSE:ALB) – Investment analysts at KeyCorp issued their Q1 2025 earnings per share estimates for shares of Albemarle in a research note issued on Sunday, April 13th. KeyCorp analyst A. Yefremov expects that the specialty chemicals company will post earnings of ($0.68) per share for the quarter. KeyCorp currently has a “Overweight” rating and a $102.00 target price on the stock. The consensus estimate for Albemarle’s current full-year earnings is ($0.04) per share. KeyCorp also issued estimates for Albemarle’s Q2 2025 earnings at ($0.35) EPS, Q3 2025 earnings at ($0.23) EPS, Q4 2025 earnings at ($0.87) EPS and FY2026 earnings at $2.75 EPS.

A number of other research analysts have also recently issued reports on the stock. Truist Financial decreased their price objective on shares of Albemarle from $85.00 to $65.00 and set a “hold” rating for the company in a report on Monday. Piper Sandler cut their price objective on shares of Albemarle from $90.00 to $85.00 and set an “underweight” rating for the company in a research report on Thursday, February 20th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Albemarle from $109.00 to $105.00 in a report on Wednesday, February 12th. Mizuho lowered their price objective on shares of Albemarle from $90.00 to $85.00 and set a “neutral” rating for the company in a research report on Friday, March 7th. Finally, BMO Capital Markets dropped their price target on shares of Albemarle from $150.00 to $140.00 in a research note on Wednesday, February 12th. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $98.70.

Albemarle Trading Up 1.1 %

ALB opened at $57.32 on Tuesday. The stock has a market capitalization of $6.74 billion, a PE ratio of -5.12 and a beta of 1.59. Albemarle has a 1-year low of $49.43 and a 1-year high of $137.50. The company has a current ratio of 1.95, a quick ratio of 1.19 and a debt-to-equity ratio of 0.39. The firm has a 50-day moving average price of $72.96 and a two-hundred day moving average price of $88.26.

Albemarle (NYSE:ALB) last released its quarterly earnings data on Wednesday, February 12th. The specialty chemicals company reported ($1.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.49). Albemarle had a negative net margin of 21.93% and a negative return on equity of 1.72%.

Institutional Investors Weigh In On Albemarle

Large investors have recently modified their holdings of the stock. TD Private Client Wealth LLC lifted its stake in shares of Albemarle by 50.4% in the 3rd quarter. TD Private Client Wealth LLC now owns 394 shares of the specialty chemicals company’s stock worth $37,000 after purchasing an additional 132 shares during the period. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Albemarle by 48.9% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 414 shares of the specialty chemicals company’s stock worth $36,000 after acquiring an additional 136 shares during the last quarter. First Community Trust NA increased its stake in shares of Albemarle by 55.0% in the 4th quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company’s stock worth $34,000 after purchasing an additional 142 shares in the last quarter. Metis Global Partners LLC grew its holdings in Albemarle by 3.9% during the fourth quarter. Metis Global Partners LLC now owns 3,908 shares of the specialty chemicals company’s stock valued at $336,000 after purchasing an additional 148 shares during the period. Finally, SlateStone Wealth LLC raised its stake in shares of Albemarle by 3.3% in the fourth quarter. SlateStone Wealth LLC now owns 4,655 shares of the specialty chemicals company’s stock worth $401,000 after buying an additional 150 shares during the period. Hedge funds and other institutional investors own 92.87% of the company’s stock.

Albemarle Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Friday, March 14th were paid a $0.405 dividend. The ex-dividend date of this dividend was Friday, March 14th. This represents a $1.62 dividend on an annualized basis and a yield of 2.83%. Albemarle’s dividend payout ratio (DPR) is presently -14.46%.

About Albemarle

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.